This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mammen, E. F. Search for Related Content PubMed Articles by Mammen, E. F. Social Bookmarking                   What's this?

Ten Years' Experience with the "Sticky Platelet Syndrome"

Departments of Pathology, Physiology, and Obstetrics and Gynecology, Wayne State University School of Medicine, Detroit, Michigan, U.S.A.

We describe a 10-year experience with a con genital platelet abnormality characterized by hyperaggre gability with ADP and/or epinephrine. The syndrome has so far been identified in >200 patients and their families. Clinical symptoms are transient or permanent arterial oc clusions, thrombotic in nature, affecting especially the coronary and cerebral vasculature, including ophthalmic vessels. The patients have no identifiable risk factors and are usually young (5-45 years), and other hypercoagula ble states are excluded. In many cases the vascular acci dent is precipitated by severe stressful events. Occasion ally the syndrome is found in patients with recurrent ve nous thromboembolism while they are on optimal oral anticoagulant therapy. In the laboratory the patients' platelets are hyperaggregable with decreasing ADP and/ or epinephrine concentrations added to platelet-rich plasma. Two forms are identified: Type I is marked by hyperaggregability with ADP and epinephrine, while Type II evidences hyperaggregability only with epineph rine. No abnormalities are found when other aggregation stimulators are used. By electron microscopy the plate lets are more readily activated by surface contact, with a greater tendency toward aggregate formation. Plasma lev els of platelet release proteins, platelet factor 4, and ß-thromboglobulin are not elevated. The syndrome is treated with low-dose aspirin, which reverses the hyper aggregability and improves clinical symptoms. We hy pothesize that in vivo adrenaline release leads to in creased platelet clumping, which can transiently or per manently occlude small vessels. It is conceivable that altered surface receptors on the platelets might be respon sible for this congenital problem.

Key Words: Key Words: Platelets • Thrombosis • Adrenaline • Platelet aggregation • Platelet adhesion • Aspirin.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. L. Bick and R. G. Scott Stasis Ulcers Refractory to Therapy--Accelerated Healing by Treatment With Clopidogrel {+/-} Dalteparin: A Preliminary Report Clinical and Applied Thrombosis/Hemostasis, January 1, 2001; 7(1): 21 - 24. [Abstract] [PDF]

				R. L. Bick Therapy for Venous Thrombosis: Guidelines for a Competent and Cost-effective Approach Clinical and Applied Thrombosis/Hemostasis, January 1, 1999; 5(1): 2 - 9. [PDF]

				R. L. Bick Sticky Platelet Syndrome: A Common Cause of Unexplained Arterial and Venous Thrombosis Clinical and Applied Thrombosis/Hemostasis, April 1, 1998; 4(2): 77 - 81. [Abstract] [PDF]

				R. L. Bick and H. Kaplan Syndromes of Thrombosis and Hypercoagulability: Congenital and Acquired Thrombophilias Clinical and Applied Thrombosis/Hemostasis, January 1, 1998; 4(1): 25 - 50. [Abstract] [PDF]

				Letters to the Editor Clinical and Applied Thrombosis/Hemostasis, September 1, 1995; 1(4): 293 - 293. [PDF]